These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 21849406)
1. 99mTc-Hydrazinonicotinamide epidermal growth factor-polyethylene glycol-quantum dot imaging allows quantification of breast cancer epidermal growth factor receptor expression and monitors receptor downregulation in response to cetuximab therapy. Jung KH; Choe YS; Paik JY; Lee KH J Nucl Med; 2011 Sep; 52(9):1457-64. PubMed ID: 21849406 [TBL] [Abstract][Full Text] [Related]
2. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225. Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869 [TBL] [Abstract][Full Text] [Related]
3. EGF receptor targeted tumor imaging with biotin-PEG-EGF linked to (99m)Tc-HYNIC labeled avidin and streptavidin. Jung KH; Park JW; Paik JY; Quach CH; Choe YS; Lee KH Nucl Med Biol; 2012 Nov; 39(8):1122-7. PubMed ID: 22819251 [TBL] [Abstract][Full Text] [Related]
4. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207 [TBL] [Abstract][Full Text] [Related]
5. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715 [TBL] [Abstract][Full Text] [Related]
6. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice. Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534 [TBL] [Abstract][Full Text] [Related]
7. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. Chen P; Cameron R; Wang J; Vallis KA; Reilly RM J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194 [TBL] [Abstract][Full Text] [Related]
8. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts. Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037 [TBL] [Abstract][Full Text] [Related]
9. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor. Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069 [TBL] [Abstract][Full Text] [Related]
11. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates. Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962 [TBL] [Abstract][Full Text] [Related]
12. PET imaging of EGFR expression in nude mice bearing MDA-MB-468, a human breast adenocarcinoma. Sadri K; Ren Q; Zhang K; Paudyal B; Devadhas D; Rodeck U; Thakur M Nucl Med Commun; 2011 Jul; 32(7):563-9. PubMed ID: 21572364 [TBL] [Abstract][Full Text] [Related]
13. MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using ¹¹¹In-labeled bispecific radioimmunoconjugates. Razumienko E; Dryden L; Scollard D; Reilly RM Breast Cancer Res Treat; 2013 Apr; 138(3):709-18. PubMed ID: 23525982 [TBL] [Abstract][Full Text] [Related]
14. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870 [TBL] [Abstract][Full Text] [Related]
15. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging. Wang K; Wang K; Li W; Huang T; Li R; Wang D; Shen B; Chen X Acta Radiol; 2009 Dec; 50(10):1095-103. PubMed ID: 19922304 [TBL] [Abstract][Full Text] [Related]
16. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors. Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447 [TBL] [Abstract][Full Text] [Related]
18. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384 [TBL] [Abstract][Full Text] [Related]
19. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model. Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064 [TBL] [Abstract][Full Text] [Related]
20. Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts. Wang J; Chen P; Mrkobrada M; Hu M; Vallis KA; Reilly RM Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1273-80. PubMed ID: 12640557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]